Connect with us

business

Curaleaf Backed Out of West Coast Markets, Almost Kicked Out of NJ 

Published

on


The cannabis industry has had its fair share of highs and lows over the last decade, as evidenced by patterns we’re seeing with some major players in the pot world. Take Curaleaf, for example, one of the largest dispensary operators in the United States. They recently decided to pull out of the most mature and well-established cannabis markets in the country – California, Colorado, and Oregon – and shortly after, had to fight to keep their license to sell recreational weed in New Jersey. What is going with Curaleaf? And what’s happening to the cannabis industry?  

Who is Curaleaf? 

Curaleaf is a well-known medical and recreational cannabis company in the United States, founded in 2010 and  headquartered in Wakefield, Massachusetts. They operate a chain of dispensaries across 17 states, with hundreds of thousands of patients nationwide. Curaleaf is publicly traded on the Canadian stock exchange (OTCQX: CURLF).  

Their valuation has fluctuated quite a bit over the last few years, with their highest numbers in the first two quarters of 2021. However, it has been on the steady decline since with shares dropping to their lowest point (under $3) in March and April of this year.  

Since January, Curaleaf has been trying to implement different measures to cut costs and get back in the black. These include mass layoffs (part of the reason they’re having issues in New Jersey), dispensary closures, a 10% payroll reduction across the board, and consolidating cultivation and processing operations in Massachusetts to a single facility in Webster. 

“These adjustments were necessary for the future success and profitability of the business, and were made as a result of recent legislative decisions, price compression, and lack of enforcement of the illicit market,” the company said. 

Why did they pull out of the West Coast markets? 

In January, Curaleaf announced that they would be closing most of their dispensaries in California, Colorado, and Oregon as part of their “continued effort to streamline business operations.” As of now, they only have one remaining store open in Oregon (on Fremont Street in Portland), and none in California or Colorado.  

Not only are they shuttering retail stores, but they are closing all production and cultivation facilities in those states as well – again, the only one left is in Massachusetts. Curaleaf cited a “difficult operating environment” in these states, due to massive oversupply of flower which has led to a dramatic drop in wholesale prices, and competition from the black market. These problems where consistent in all three states they plan on leaving. California is infamous for these issues, Colorado has seen prices plummet in the last few years, and Oregon is one of the most oversupplied markets in the country.  

Company representatives state that they will “place a laser focus on cash generation in its core revenue-driving markets moving forward.” CEO Matt Darrin says Curaleaf will place greater efforts on expanding operations in newer markets across the US. “We’re seeing the growth opportunities and the greatest opportunities in markets that may not be the markets where some of that took place years ago. So as the industry matures, we are focused on the markets that are generating strong profits and are very stable markets.” 

What happened in New Jersey? 

Last week, it was announced that Curaleaf would be kicked out of New Jersey’s recreational cannabis market over “labor practices”. Basically what this means, is that NJ officials voted against renewing Curaleaf’s license to grow and sell weed because the company did not properly notify the state’s Cannabis Regulatory Commission about employee layoffs. The company was in the process of shutting down two of its NJ locations. 


Thank you for stopping in. Head over to the Cannadelics Weekly Newsletter for direct updates; and get access to awesome deals on cannabis buds, vapes, edibles, smoking devices and equipment, cannabinoid compounds, and some psychedelic products! Go get high responsibly!


But in an interesting change of heart, The Board of the New Jersey Cannabis Regulatory (CRC) reversed course, and voted during an emergency meeting on Monday to reapprove Curaleaf’s adult-use recreational cannabis license renewal. So, their license that was set to expire on April 21st, will be reinstated, and their recreational stores in Bordentown, Bellmawr, and Edgewater Park can continue operations.  

Curaleaf’s dispensaries have generated more than $5 million in tax revenue dollars for the state of New Jersey, according to the company’s chief compliance officer, James Shorris. He also added that the “company has bargained in good faith with New Jersey employees who have joined the United Food and Commercial Workers Local 360.”  

That being said, the company has had a spotty record with labor issues in the past. Last year, the National Labor Relations Board issued a citation to Curaleaf for refusing to work out a deal with unionized workers in Chicago, Illinois and Phoenix, Arizona. Many states are implementing laws that require companies to bargain with employees if the majority of them want to discuss unionizing.  

The future of cannabis  

Although legalization is overall a good thing (people getting arrested for cannabis possession is ridiculous, I think we can all agree to that), the bottom line is, the industry is not generating nearly as much revenue as anticipated, and businesses are struggling. Pretty much everyone in the supply chain including cultivators, extractors, dispensary owners, and even those operating ancillary businesses like software and technology are feeling the pain of this stressed market.  

But the problem is not demand, people are still buying weed in the same numbers, if not more so, than in years prior. There’s been a huge uptick in middle-aged to older Americans who use cannabis products as well. So it’s not that people are losing interest in weed, although the culture has changed dramatically, it’s because of numerous different elements that make it difficult for weed business to make a profit – mainly taxes and the still-thriving black market.  

Cannabis businesses are notoriously overtaxed. Then factor in the many other costs and fees associated with operating a weed business, and it translates to higher prices for consumers. Higher than what they would find from a street dealer or unlicensed (black-market) dispensary. And because these unregulated distributors have access to all the same products, sometimes better ones, than legal dispensaries, that makes for an extremely hostile and competitive environment for any trying to operate an above-board cannabis business.  

The are quite a few other issues with today’s cannabis market, such as oversupply of flower – to the point that growers are having trouble selling off much of their stock, difficulty advertising on prominent search engines and social media sites, problems finding property and real estate for their business endeavors, banking/financing struggles, and the list goes on.  

In response, big players in the industry are trying to cut costs in any way possible; from mass layoffs and salary cuts, to store closures, and even taking shortcuts on the production side of things. Investors are taking note as well, and they are growing increasingly reluctant to invest in cannabis-related enterprises. Summarized, the cannabis industry is not faring well at the moment, and these cost-cutting measures are likely to continue well into 2024.

Final thoughts  

Although we can’t base everything on one single company, the fact that they, and other big names in the industry are voluntarily backing out of the OG cannabis markets, is very telling. It tells us that if state governments don’t get a handle on the taxes and fees charged, and unnecessary hoops they make cannabis business owners jump through, the black market will continue to outpace the legal one.

Welcome readers! Thanks for hanging out with us at Cannadelics.com; an independent publication that brings you new and ongoing stories in the cannabis and hallucinogen spaces. Come ’round regularly so you don’t miss out on anything; and subscribe to our Cannadelics Weekly Newsletter, to ensure you’re never late to get the news.



Source link

Continue Reading

business

Marijuana rescheduling leaves regulators and sellers cautiously optimistic

Published

on

By



A move by the Biden Administration to change how marijuana is treated by federal authorities was met with cautious approval by Massachusetts state regulators, cannabis sellers, and national marijuana advocates alike.

The Drug Enforcement Agency will drop marijuana from the list of banned substances found under Schedule I of the Controlled Substances Act, where it currently sits alongside heroin and LSD. It will instead move it to Schedule III, among the likes of Tylenol with codeine and anabolic steroids. This follows the recommendation of the Department of Health and Human Services

“Rescheduling cannabis is a monumental step forward for the federal government, one that can open new avenues to research, medical use, and banking for the regulated industries states like Massachusetts have built across the country,” said Ava Callender Concepcion, the acting chair of the Bay State’s Cannabis Control Commission.

Read the rest of this story on BostonHerald.com.



Source link

Continue Reading

business

Thailand Considers Relisting Cannabis as a Narcotic

Published

on

By


The Thai government is contemplating the relisting of cannabis as a narcotic due to concerns over its recreational use and potential societal harms. This reconsideration comes after cannabis was decriminalized in June 2022, which led to a surge in its availability and use.

Cannabis Conundrum: Thailand Reconsiders Legal Status Amidst Rising Concerns

The recent decriminalization of cannabis in Thailand has ignited a complex debate over its legal status and societal impact. While the policy aimed to boost the medical marijuana industry and provide economic opportunities, the unintended rise in recreational use has sparked discussions about a potential reclassification.

Public Health Minister Anutin Charnvirakul, a key advocate for the decriminalization, emphasized that the policy was intended to promote medical use, not recreational. However, the current legal framework lacks clear regulations governing recreational use, leading to widespread availability and potential misuse.

The Bhumjaithai Party, led by Anutin, initially pushed for the delisting of cannabis to benefit the medical industry and provide economic opportunities for Thai citizens. However, the subsequent surge in recreational use, particularly among youths, has raised concerns about potential health and social consequences.

Opposition parties have criticized the government for inadequate regulations and are advocating for cannabis to be relisted as a narcotic under the Narcotics Act. They argue that the current situation exposes young people to potential harm and lacks sufficient safeguards.

A recent poll revealed that a majority of Thais support stricter regulations on cannabis use. Concerns have been raised about the potential impact on public health, particularly regarding mental health issues and addiction, especially among youths. Additionally, there are worries about the potential for increased crime and social disorder.

The government now faces the challenge of balancing the economic benefits of a burgeoning cannabis industry with the need to protect public health and safety. Finding a solution that addresses the concerns of both advocates and critics will be crucial in determining the future of cannabis in Thailand

Why It Matters

Thailand’s shift in cannabis policy has garnered international attention, serving as a case study for the complexities of drug policy reform. The potential reclassification of cannabis underscores the challenges of balancing economic opportunities with public health and safety considerations. The outcome of this debate will have significant implications for Thailand’s legal landscape, public health policies, and the future of its cannabis industry.

Potential Implications of Relisting Cannabis as a Narcotic

If cannabis is relisted as a narcotic, it could lead to stricter regulations on its cultivation, distribution, and use. This may impact the growth of the medical marijuana industry and limit access for patients who rely on cannabis for therapeutic purposes. Additionally, it could result in increased criminal penalties for possession and use, potentially leading to a rise in incarceration rates.

Alternatively, if the government opts to maintain the decriminalized status, it will need to implement robust regulations and public health campaigns to mitigate the risks associated with recreational use. This includes age restrictions, educational initiatives, and support systems for individuals struggling with cannabis dependence.

The Bigger Picture

The debate surrounding cannabis legalization and regulation is a global phenomenon, with countries around the world grappling with similar challenges. The Thai government’s decision regarding cannabis will likely be influenced by international trends and best practices in drug policy reform. It is crucial to consider the experiences of other nations that have legalized or decriminalized cannabis, examining both the successes and challenges they have encountered.

Source: Thai PBS World



Source link

Continue Reading

banking

“A big deal”: What the feds’ move to reclassify marijuana means for Colorado cannabis

Published

on

By



Cannabis advocates in Colorado cheered the Biden Administration’s reported move to reclassify marijuana and said the decision likely would reduce businesses’ tax burden significantly.

Industry leaders cautioned that such a move — if finalized — would not resolve some major challenges facing the industry, such as limited access to banking. But they pointed to the symbolic importance of preparations by the U.S. Drug Enforcement Administration to downgrade the substance’s drug classification.

A man pours cannabis into rolling papers as he prepares to roll a joint the Mile High 420 Festival in Civic Center Park in Denver, April 20, 2024. (Photo by Kevin Mohatt/Special to The Denver Post)

Read the rest of this story on DenverPost.com.



Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media